Rajiv Radhakrishnan

4.3k total citations
83 papers, 2.5k citations indexed

About

Rajiv Radhakrishnan is a scholar working on Pharmacology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rajiv Radhakrishnan has authored 83 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pharmacology, 24 papers in Psychiatry and Mental health and 21 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rajiv Radhakrishnan's work include Cannabis and Cannabinoid Research (24 papers), Schizophrenia research and treatment (15 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Rajiv Radhakrishnan is often cited by papers focused on Cannabis and Cannabinoid Research (24 papers), Schizophrenia research and treatment (15 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Rajiv Radhakrishnan collaborates with scholars based in United States, India and United Kingdom. Rajiv Radhakrishnan's co-authors include Deepak Cyril D’Souza, Chittaranjan Andrade, Samuel T. Wilkinson, Mohini Ranganathan, Patrick D. Skosnik, Mohamed Sherif, Sinan Gülöksüz, Brian Pittman, Stephanie Yarnell and Samuel A. Ball and has published in prestigious journals such as SHILAP Revista de lepidopterología, NeuroImage and American Journal of Psychiatry.

In The Last Decade

Rajiv Radhakrishnan

78 papers receiving 2.4k citations

Peers

Rajiv Radhakrishnan
Rajiv Radhakrishnan
Citations per year, relative to Rajiv Radhakrishnan Rajiv Radhakrishnan (= 1×) peers José A. Crippa

Countries citing papers authored by Rajiv Radhakrishnan

Since Specialization
Citations

This map shows the geographic impact of Rajiv Radhakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rajiv Radhakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rajiv Radhakrishnan more than expected).

Fields of papers citing papers by Rajiv Radhakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rajiv Radhakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rajiv Radhakrishnan. The network helps show where Rajiv Radhakrishnan may publish in the future.

Co-authorship network of co-authors of Rajiv Radhakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Rajiv Radhakrishnan. A scholar is included among the top collaborators of Rajiv Radhakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rajiv Radhakrishnan. Rajiv Radhakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Syed, Shariful A., et al.. (2025). International perspectives on physician knowledge, attitudes, and practices related to medical cannabis. Frontiers in Public Health. 13. 1463871–1463871. 1 indexed citations
2.
Volpi, Tommaso, Shannan Henry, Mark Dias, et al.. (2025). Carotid Artery Image-Derived Blood Time–Activity Curves on the NeuroEXPLORER: Initial Multitracer Validation Against Arterial Sampling. Journal of Nuclear Medicine. 66(12). jnumed.125.270414–jnumed.125.270414.
3.
Nunes, Eric J., et al.. (2024). Substance use and spine density: a systematic review and meta-analysis of preclinical studies. Molecular Psychiatry. 29(9). 2873–2885. 3 indexed citations
4.
Nikayin, Sina, et al.. (2024). Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical Setting. The Journal of Clinical Psychiatry. 85(4). 5 indexed citations
5.
Jha, Manish K., et al.. (2023). Role of Psychedelics in Treatment-Resistant Depression. Psychiatric Clinics of North America. 46(2). 291–305. 16 indexed citations
6.
Radhakrishnan, Rajiv, Lotta-Katrin Pries, Gamze Erzın, et al.. (2022). Bidirectional relationships between cannabis use, anxiety and depressive symptoms in the mediation of the association with psychotic experience: further support for an affective pathway to psychosis. Psychological Medicine. 53(12). 5551–5557. 5 indexed citations
7.
Radhakrishnan, Rajiv, Patrick D. Worhunsky, Ming‐Qiang Zheng, et al.. (2022). Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET. NeuroImage. 264. 119674–119674. 6 indexed citations
8.
Ranganathan, Mohini, Suhas Ganesh, Deepak Cyril D’Souza, et al.. (2021). Analysis of circulating exosomes reveals a peripheral signature of astrocytic pathology in schizophrenia. The World Journal of Biological Psychiatry. 23(1). 33–45. 32 indexed citations
9.
Radhakrishnan, Rajiv, Patrick D. Skosnik, Mohini Ranganathan, et al.. (2021). In vivo evidence of lower synaptic vesicle density in schizophrenia. Molecular Psychiatry. 26(12). 7690–7698. 61 indexed citations
10.
Fang, Xiaotian T., Takuya Toyonaga, Ansel T. Hillmer, et al.. (2021). Identifying brain networks in synaptic density PET (11C-UCB-J) with independent component analysis. NeuroImage. 237. 118167–118167. 19 indexed citations
11.
Dwyer, Jennifer B., Awais Aftab, Rajiv Radhakrishnan, et al.. (2020). Hormonal Treatments for Major Depressive Disorder: State of the Art. American Journal of Psychiatry. 177(8). 686–705. 165 indexed citations
12.
Tsai, Jack, Dorota Szymkowiak, & Rajiv Radhakrishnan. (2020). Antipsychotic Medication Prescriptions for Homeless and Unstably Housed Veterans in the Veterans Affairs Health Care System. The Journal of Clinical Psychiatry. 82(1). 5 indexed citations
13.
D’Souza, Deepak Cyril, Rajiv Radhakrishnan, Mohamed Sherif, et al.. (2017). Cannabinoids and Psychosis. Current Pharmaceutical Design. 22(42). 6380–6391. 30 indexed citations
14.
Sherif, Mohamed, Rajiv Radhakrishnan, Deepak Cyril D’Souza, & Mohini Ranganathan. (2016). Human Laboratory Studies on Cannabinoids and Psychosis. Biological Psychiatry. 79(7). 526–538. 91 indexed citations
15.
Thomas, Tinku, et al.. (2013). Heart rate variability responses to standing are attenuated in drug naive depressed patients.. PubMed. 56(3). 213–21. 6 indexed citations
17.
Ranganathan, Mohini, Michelle Carbuto, Gabriel Braley, et al.. (2012). Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The International Journal of Neuropsychopharmacology. 15(9). 1251–1264. 21 indexed citations
18.
Andrade, Chittaranjan, et al.. (2012). Psychopharmacology of schizophrenia: The future looks bleak. PubMed. 10(1). 4–4. 5 indexed citations
19.
Radhakrishnan, Rajiv & Chittaranjan Andrade. (2012). Suicide: An Indian perspective. Indian Journal of Psychiatry. 54(4). 304–304. 154 indexed citations
20.
Andrade, Chittaranjan & Rajiv Radhakrishnan. (2009). Prayer and healing: A medical and scientific perspective on randomized controlled trials. Indian Journal of Psychiatry. 51(4). 247–247. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026